Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men

Min-Jeong Shin, Ronald M. Krauss

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Objective: Plasma levels of both apolipoprotein CIII (apoCIII) and small, dense LDL particles are associated with plasma triglyceride (TG) concentrations, and are markers for cardiovascular disease (CVD) risk. We tested whether there is an association of apoCIII with small, dense LDL levels that is independent of plasma TG level. Methods: For study I, concentrations of blood lipids, apolipoproteins, and LDL subfractions (analytical ultracentrifugation, AnUC) were measured in 141 healthy middle-aged males. In study II (n=14), density gradient ultracentrifugation of plasma was performed, and 3 fractions in the LDL density range (1.019-1.063. g/ml) were collected. Results: In study I, plasma levels of apoCIII in apoB-containing lipoproteins (LpB:CIII) were associated positively with concentrations of LDL3 (p<0.001) and LDL4 (p<0.001) and negatively with LDL peak particle size (p<0.05) with adjustment for plasma TG. Stepwise multiple regression analysis showed that LpB:CIII was significantly associated with small, dense LDL (LDL3. +. LDL4) levels after adjusting for age, BMI, plasma levels of TG, apoB, and HDL-cholesterol. In study II, the molar ratio of apoCIII to apoB in the LDL fraction of highest density (1.049-1.064. g/ml) was found to be significantly greater (p<0.001) than that in each of two LDL fractions of lower density (1.033-1.038. g/ml; p<0.001 and 1.038-1.049. g/ml; p<0.001). Conclusions: Increased apoCIII content may contribute to metabolic and pathologic properties of small, dense LDL particles.

Original languageEnglish
Pages (from-to)337-341
Number of pages5
JournalAtherosclerosis
Volume211
Issue number1
DOIs
Publication statusPublished - 2010 Jul 1

Fingerprint

Apolipoprotein C-III
Apolipoproteins B
Lipoproteins
Triglycerides
Ultracentrifugation
Apolipoproteins
oxidized low density lipoprotein
Particle Size
HDL Cholesterol
Cardiovascular Diseases
Regression Analysis
Lipids

Keywords

  • Apolipoprotein CIII
  • Atherogenic lipoprotein phenotype
  • Coronary heart disease
  • Small dense LDL

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men. / Shin, Min-Jeong; Krauss, Ronald M.

In: Atherosclerosis, Vol. 211, No. 1, 01.07.2010, p. 337-341.

Research output: Contribution to journalArticle

@article{84c03233c18347d2be07007c1727aac5,
title = "Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men",
abstract = "Objective: Plasma levels of both apolipoprotein CIII (apoCIII) and small, dense LDL particles are associated with plasma triglyceride (TG) concentrations, and are markers for cardiovascular disease (CVD) risk. We tested whether there is an association of apoCIII with small, dense LDL levels that is independent of plasma TG level. Methods: For study I, concentrations of blood lipids, apolipoproteins, and LDL subfractions (analytical ultracentrifugation, AnUC) were measured in 141 healthy middle-aged males. In study II (n=14), density gradient ultracentrifugation of plasma was performed, and 3 fractions in the LDL density range (1.019-1.063. g/ml) were collected. Results: In study I, plasma levels of apoCIII in apoB-containing lipoproteins (LpB:CIII) were associated positively with concentrations of LDL3 (p<0.001) and LDL4 (p<0.001) and negatively with LDL peak particle size (p<0.05) with adjustment for plasma TG. Stepwise multiple regression analysis showed that LpB:CIII was significantly associated with small, dense LDL (LDL3. +. LDL4) levels after adjusting for age, BMI, plasma levels of TG, apoB, and HDL-cholesterol. In study II, the molar ratio of apoCIII to apoB in the LDL fraction of highest density (1.049-1.064. g/ml) was found to be significantly greater (p<0.001) than that in each of two LDL fractions of lower density (1.033-1.038. g/ml; p<0.001 and 1.038-1.049. g/ml; p<0.001). Conclusions: Increased apoCIII content may contribute to metabolic and pathologic properties of small, dense LDL particles.",
keywords = "Apolipoprotein CIII, Atherogenic lipoprotein phenotype, Coronary heart disease, Small dense LDL",
author = "Min-Jeong Shin and Krauss, {Ronald M.}",
year = "2010",
month = "7",
day = "1",
doi = "10.1016/j.atherosclerosis.2010.02.025",
language = "English",
volume = "211",
pages = "337--341",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men

AU - Shin, Min-Jeong

AU - Krauss, Ronald M.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Objective: Plasma levels of both apolipoprotein CIII (apoCIII) and small, dense LDL particles are associated with plasma triglyceride (TG) concentrations, and are markers for cardiovascular disease (CVD) risk. We tested whether there is an association of apoCIII with small, dense LDL levels that is independent of plasma TG level. Methods: For study I, concentrations of blood lipids, apolipoproteins, and LDL subfractions (analytical ultracentrifugation, AnUC) were measured in 141 healthy middle-aged males. In study II (n=14), density gradient ultracentrifugation of plasma was performed, and 3 fractions in the LDL density range (1.019-1.063. g/ml) were collected. Results: In study I, plasma levels of apoCIII in apoB-containing lipoproteins (LpB:CIII) were associated positively with concentrations of LDL3 (p<0.001) and LDL4 (p<0.001) and negatively with LDL peak particle size (p<0.05) with adjustment for plasma TG. Stepwise multiple regression analysis showed that LpB:CIII was significantly associated with small, dense LDL (LDL3. +. LDL4) levels after adjusting for age, BMI, plasma levels of TG, apoB, and HDL-cholesterol. In study II, the molar ratio of apoCIII to apoB in the LDL fraction of highest density (1.049-1.064. g/ml) was found to be significantly greater (p<0.001) than that in each of two LDL fractions of lower density (1.033-1.038. g/ml; p<0.001 and 1.038-1.049. g/ml; p<0.001). Conclusions: Increased apoCIII content may contribute to metabolic and pathologic properties of small, dense LDL particles.

AB - Objective: Plasma levels of both apolipoprotein CIII (apoCIII) and small, dense LDL particles are associated with plasma triglyceride (TG) concentrations, and are markers for cardiovascular disease (CVD) risk. We tested whether there is an association of apoCIII with small, dense LDL levels that is independent of plasma TG level. Methods: For study I, concentrations of blood lipids, apolipoproteins, and LDL subfractions (analytical ultracentrifugation, AnUC) were measured in 141 healthy middle-aged males. In study II (n=14), density gradient ultracentrifugation of plasma was performed, and 3 fractions in the LDL density range (1.019-1.063. g/ml) were collected. Results: In study I, plasma levels of apoCIII in apoB-containing lipoproteins (LpB:CIII) were associated positively with concentrations of LDL3 (p<0.001) and LDL4 (p<0.001) and negatively with LDL peak particle size (p<0.05) with adjustment for plasma TG. Stepwise multiple regression analysis showed that LpB:CIII was significantly associated with small, dense LDL (LDL3. +. LDL4) levels after adjusting for age, BMI, plasma levels of TG, apoB, and HDL-cholesterol. In study II, the molar ratio of apoCIII to apoB in the LDL fraction of highest density (1.049-1.064. g/ml) was found to be significantly greater (p<0.001) than that in each of two LDL fractions of lower density (1.033-1.038. g/ml; p<0.001 and 1.038-1.049. g/ml; p<0.001). Conclusions: Increased apoCIII content may contribute to metabolic and pathologic properties of small, dense LDL particles.

KW - Apolipoprotein CIII

KW - Atherogenic lipoprotein phenotype

KW - Coronary heart disease

KW - Small dense LDL

UR - http://www.scopus.com/inward/record.url?scp=77954246799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954246799&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2010.02.025

DO - 10.1016/j.atherosclerosis.2010.02.025

M3 - Article

C2 - 20303494

AN - SCOPUS:77954246799

VL - 211

SP - 337

EP - 341

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -